• SWC 2014 Website Banner

  • slide_croi2014

  • slideshow_inform4

  • slide_prepvideos

  • Slideshow_prep

Project Inform sponsors legislation in California to increase hepatitis C testing


In April 2014, State Senator Norma Torres (D-Ontario) introduced SB 1303 into the State Legislature. Project Inform is the sponsor of the bill, in conjunction with Cal-HEP, the state’s viral hepatitis advocacy coalition. SB 1303 seeks to address the fact that up to 70 percent of…Read More

Meet Emalie Huriaux, PI’s New Director of State & Federal Affairs


Project Inform is proud and excited to announce that Emalie Huriaux began work with us on April 14 as our new Director of State & Federal Affairs. This position will primarily be responsible for our hepatitis C policy related activities at the national level and in…Read More

Honoring Anne Donnelly on her 25th Anniversary with Project Inform


Twenty-five years ago, amidst the loss of countless dear friends and colleagues, Anne Donnelly left a comfortable corporate job to work for Project Inform. She began her career with us doing critical fundraising work, but soon helped lead advocacy to increase funding to the National Institutes…Read More

New all-oral hepatitis C regimen submitted to FDA for approval


As the field of hepatitis C (HCV) treatment moves further into the era of directly acting agents (DAAs), AbbVie has submitted an application to the FDA for approval for their all-oral, interferon-free HCV regimen for treating patients with genotype 1 (GT1). This genotype is the most…Read More

California improves access to HIV prevention pill


Important new tool in fighting AIDS, Pre-exposure prophylaxis (PrEP) may be up to 99% effective in preventing new infections Three leading California AIDS organizations — AIDS Project Los Angeles, the L.A. Gay & Lesbian Center and Project Inform in San Francisco — today applauded California’s Medi-Cal…Read More

Wisconsin testing initiative reports high rate of undiagnosed hepatitis C among injection drug users


Most new hepatitis C (HCV) infections are the result of sharing syringes and other injecting equipment among people who inject drugs. In recent years, the CDC has reported an increase in new HCV infections, and New York and Massachusetts has also reported several outbreaks of HCV…Read More

FDA priority review status granted for hepatitis C combo pill of ledipasvir and sofosbuvir


In another step of the ever-changing landscape for treating hepatitis C infection, the FDA has granted a Breakthrough Therapy designation and priority review status for the new once-a-day combination pill of ledipasvir and sofsobuvir. The combination is used to treat genotype 1, which nearly 75% of…Read More